US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.35

-0.2723-0.61%

Post-market: 44.350.00000.00%16:10 EDT

Volume:3K

Turnover:116.71K

Market Cap:5.54M

PE:- -

High:44.71

Open:44.71

Low:44.35

Close:44.62

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.65

T/O Rate:2.10%

Dividend:0.62

Dividend Rate:1.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Global Drugmakers Invest Billions to Boost US Presence

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS

Erasca Appoints Charles Fuchs as President of R&D

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

Sanofi, Regeneron Seem Keen to Keep Working Together

Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors

Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline

Moderna Inc. Stock Sheds 4.3%, Underperforms Peers

Regeneron Posts Transcript of Q2 2026 Earnings Conference Call

Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River

Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma

Regeneron announces Health Canada approval of new indication for Libtayo

Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TBXU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.3509,"timestamp":1787774400000,"preClose":44.6232,"halted":0,"volume":2619,"hourTrading":{"tag":"盘后","latestPrice":44.3509,"preClose":44.3509,"latestTime":"16:10 EDT","volume":7,"amount":310.4563,"timestamp":1787775005093,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.006102206923752538,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Post-Mkt","change":-0.2723,"latestTime":"08-26 18:26:24 EDT","open":44.71,"high":44.71,"low":44.35,"amount":116714,"amplitude":0.008068,"askPrice":50.56,"askSize":10,"bidPrice":37.5,"bidSize":30,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":44.6232,"sharesOutstanding":100001,"nav":44.014,"aum":5501832.71,"dividendRate":0.01402,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.3509,"preClose":44.3509,"latestTime":"16:10 EDT","volume":7,"amount":310.4563,"timestamp":1787775005093,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.651655},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.651655,"shares":125000,"dividePrice":0.6218,"high":44.71,"amplitude":0.008068,"preClose":44.6232,"low":44.35,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":44.3509,"committee":0.5,"eps":0,"divideRate":0.01402,"volume":2619,"delay":0,"ttmEps":0,"open":44.71,"prevYearClose":31.065,"prevWeekClose":44.4163,"prevMonthClose":34.3127,"prevQuarterClose":32.1223,"fiveDayClose":44.7799,"twentyDayClose":33.7939,"sixtyDayClose":27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","LU1228905037.USD","GLAM","SG9999014898.SGD","LU1988902786.USD","LU0211327993.USD","LU1674673691.USD","LU2746668974.SGD","LU2896262040.SGD","LU1989772840.SGD","LU0210528500.USD","IE0004445015.USD","IE0001KFT4U8.USD","TMED","GSK.UK","LU0225283273.USD","LU2471134523.USD","LU1066051498.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU0859254822.USD","BK4568","IE00BZ1G4Q59.USD","LU1670711123.USD","LU0345769631.USD","LU1670711040.USD","LU2462157665.USD","LU0868494708.USD","IE00BBT3K403.USD","LU2168564495.EUR","BK4592","LU2462591350.SGD","SG9999001176.SGD","LU0310800379.SGD","LU1829250122.USD","LU0162691827.USD","IE00BK4W5L77.USD","IXJ","LU0795875169.SGD","BK7067","BIB","LU2129689605.HKD","LU1116320737.USD","LU1127390331.HKD","LU1145028129.USD","PAWZ","LU0109394709.USD","SG9999015986.USD","FTXH","SG9999014880.SGD","IE0000B7K699.USD","ABBV","IE00BLSP4239.USD","LU2125154778.USD","LU0395794307.EUR","JDOC","LU1261432733.SGD","PJP","LU0323591593.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0689626769.HKD","IE00B42XCP33.USD","LU1720051108.HKD","LU0097036916.USD","BK4581","LU2129689431.USD","LU2324357040.USD","LU1069347547.HKD","MEDI","IE00BFXG1179.USD","LU0058720904.USD","LLYZ","GSKH","LU0079474960.USD","LU0211328371.USD","LU0289739343.SGD","LU1868836591.USD","LU0320765489.SGD","IE00BVYPNW00.USD","LU1623119135.USD","LU0072461881.USD","LU0345769128.USD","LU2211815571.USD","LU1923622614.USD","LU1868836757.USD","LU1914381329.SGD","LU0238689110.USD","IE00BK4W5M84.HKD","LU0174119429.USD","LU1064131342.USD","LU2108987350.USD","LU1267930490.SGD","04332","IE00B19Z3B42.SGD","BK7501","BK4583","LU0965509283.SGD","GB00BDT5M118.USD","LU1023059063.AUD","IE00BKPKM429.USD","LU2028103732.USD","LU0158827781.USD","LU2360032135.SGD","LU0683600562.USD","LU2756315664.SGD","IE00B4R5TH58.HKD","LU1868836914.USD","SGXZ81514606.USD","LU0306807586.USD","LU2491049909.HKD","IE00BLSP4452.SGD","LU1894683348.USD","SGXZ31699556.SGD","SG9999014575.USD","LU2111349929.HKD","LU1917777945.USD","IE00BFSS8Q28.SGD","LU0320765646.SGD","LU2089284900.SGD","LU1057294990.SGD","LU0237698245.USD","LU2433249047.HKD","AMGN","LU2347655073.USD","LLYX","LU1935042991.SGD","IE00BVYPNV92.GBP","LU1074936037.SGD","LU1116320901.HKD","TRUH","IE000BZT7R73.USD","SG9999015978.USD","LU0053666078.USD","LU0820562030.AUD","LU0234570918.USD","LU0354030438.USD","LU0943347566.SGD","LU2237443465.HKD","LU0964807845.USD","LU2125909247.SGD","LU1059921491.USD","LU0354030511.USD","LU1244550494.USD","LU0208291251.USD","LU2237443549.SGD","LU0477156953.USD","SG9999014906.USD","IE00BKDWB100.SGD","IE0034235303.USD","BK4532","LU1035773651.USD","LU2106854487.HKD","LU2430703178.SGD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU2552382132.HKD","LU2505996509.AUD","LU0133085943.USD","IE000MB6IJN5.SGD","IE00BDGV0183.EUR","LU1670627923.USD","SG9999001176.USD","AZNH","LU0316494557.USD","IE00B2B36J28.USD","LU0210536198.USD","LU0471298694.HKD","LU1979441026.SGD","LU1670628061.USD","LU2242646821.SGD","SG9999014567.USD","AZN","LU1548497426.USD","LU1929549753.HKD","LU1629891620.HKD","RXL","IE000M9KFDE8.USD","LU0225284248.USD","IE00BWXC8680.SGD","BK4585","LU1571399168.USD","IE0005OL40V9.USD","LU1814569148.SGD","CSL.AU","LU1699723380.USD","LU2417539215.USD","LU0266013472.USD","IE00B1BXHZ80.USD","LU1868837300.USD","LU0949170772.SGD","LU1043141123.HKD","IHE","LU0820561909.HKD","LU0708995401.HKD","LU2168564149.EUR","LU2168563687.JPY","VHT","GSK","LU0985481810.HKD","IE00BJJMRY28.SGD","THNR","LU2264538146.SGD","LU1496350502.SGD","WDNA","BIIB","LU2461242641.AUD","ELIL","IBBQ","SG9999002232.USD","LU2360106947.USD","LU2361044865.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0432979614.USD","IE00B775H168.HKD","LU0203202063.USD","LU0353189763.USD","LU1778281490.HKD","LU1974910355.USD","LU0061475181.USD","LU1989771016.USD","LU0553294199.USD","LU2357627491.SGD","IE00BKVL7J92.USD","ILDR","LU2265009873.SGD","LU1280957306.USD","LU1221951129.SGD","LU2063271972.USD","SG9999015952.SGD","LU1221951046.USD","LU1003077747.HKD","IE00B19Z9P08.USD","LU1232071149.USD","LU0786609619.USD","LU0320765059.SGD","LU0672654240.SGD","LU2750360997.AUD","LU0158827948.USD","IBB","SG9999017495.SGD","LU0006306889.USD","LU0942090050.USD","LU1121112475.USD","MHIP","SG9999014542.SGD","LU0321505439.SGD","LU0234572021.USD","LU1244550221.USD","LU0114720955.EUR","LU0472753341.HKD","LU2430703095.HKD","SGXZ99366536.SGD","LU0648001328.SGD","LU0417517546.SGD","LU2237443978.SGD","BBH","LU0823434583.USD","BK4578","LU0738911758.USD","LU2087621335.USD","IE00BN8TJ469.HKD","IE00B1XK9C88.USD","LU0265550359.USD","LU2487616109.SGD","IE00BN29S564.USD","LLY","LU0640476718.USD","LU1267930730.SGD","LU0353189680.USD","LU0426412945.USD","LU0070302665.USD","BK4007","LU2357305700.SGD","LU1291159041.SGD","GILD","LU1868837136.USD","LU1201861249.SGD","SG9999001440.SGD","LU1732800096.USD","LU1712237335.SGD","LU0823434740.USD","LU2403377893.USD","BK4533","LU0198837287.USD","LU1670710588.SGD","LU1839511570.USD","LU1674673428.USD","LU1718418525.SGD","LU2596442595.SGD","IE00B4JS1V06.HKD","LU0203201768.USD","LU2089984988.USD","LU2430703251.USD","IYH","LU0820561818.USD","LU2491050154.USD","LU1323610961.USD","SG9999018857.SGD","LU2552382215.SGD","IE00BGHQF631.EUR","LU0096364046.USD","IE00B894F039.SGD","LU0289961442.SGD","LU0792757196.USD","LU2023250330.USD","BK4504","LU0310799852.SGD","LU2750360641.GBP","IE000F7OJYX1.SGD","SG9999002224.SGD","ELIS","LU0256863811.USD","LU0098860793.USD","LU0795875086.SGD","IE00B19Z3581.USD","LU2168564222.USD","LU0661504455.SGD","SG9999015341.SGD","LU2237438978.USD","LU0057025933.USD","LU2133065610.SGD","LU0787776722.HKD","LU0965509101.SGD","LU0385154629.USD","IE00BFSS7M15.SGD","CURE","LU1037948897.HKD","LU2125909593.SGD","BK7508","IE000SO60NU8.SGD","LU0726765562.USD","JNJ","LU0511384066.AUD","LU1066051811.HKD","LU1196500208.SGD","LU1366192091.USD","LU2602419157.SGD","LU0320765992.SGD","LU2237443382.USD","LU2087625088.SGD","SGXZ51526630.SGD","LU0882574139.USD","LU1267930573.SGD","IE0002141913.USD","LLII","SG9999014559.SGD","LU2112291526.USD","LU0545039389.USD","LU0823416689.USD","LU2023250843.SGD","SG9999018865.SGD","LU1244550577.SGD","OZEM","LU2756315318.SGD","LU2129689514.USD","LU1066051225.USD","LU1551013425.SGD","LU1069344957.HKD","LU2237443895.HKD","LU2023250504.SGD","LU2456880835.USD","FHLC","LU0466842654.USD","LU0426417589.USD","LU0980610538.SGD","LU1934455863.HKD","BK4516","IE00BJJMRZ35.SGD","LU0211331839.USD","LU2089283258.USD","LU1551013342.USD","LU2746668461.USD","LU2236285917.USD","IE00B3PB1722.GBP","LU1228905540.USD","LU1093756325.SGD","IE00BJJMRX11.SGD","LU0109391861.USD","LU0321505868.SGD","LU2471134796.USD","LU2592432038.USD","LU0256863902.USD","SG9999014914.USD","LU1585245621.USD","LU1934455277.USD","LU0124676726.USD","LU0456855351.SGD","LU0912757837.SGD","CANC","LU1989772923.USD","SG9999013999.USD","IE000WAW04H5.SGD","BK7511","LU0106261372.USD","LU1941712348.USD","TBXU","LU2242652126.USD","LU1506573853.SGD","LU0265550946.USD","SGXZ80539844.SGD","PBE","LU0029864427.USD","IE00B7KXQ091.USD","LU2125154935.USD","LU1804176565.USD","GDOC","LU1941712264.USD","LU0130517989.USD","LU0128525929.USD","LU2347655156.SGD","LU2505996681.GBP","LU0267386448.USD","LU2023251221.USD","LU1162221912.USD","BK4559","LU1061106388.HKD","SG9999011175.SGD","IE00B19Z9Z06.USD","LU0094547139.USD","LU1035775433.USD","LU1496350171.SGD","LU0289739699.SGD","LU1720051017.SGD","LU0994945656.USD","LU2271345857.HKD","LU0708994859.HKD","LU1430594728.SGD","LU0122379950.USD","AGNG","LU1883839398.USD","PPH","MRK","LU2471134952.CNY","HRTS","SG9999015358.SGD","LU0861579265.USD","LU0689472784.USD","LU0985320562.USD","LU0965509010.AUD","LU1894683264.USD","LU0203345920.USD","LU1732799900.SGD","LU2237443622.USD","IE0004445239.USD","SG9999003800.SGD","LU1093756168.USD","LU2468319806.SGD","BMED","BK4534","LU0345770308.USD","LU1037948541.HKD","LU0965508806.USD","MEDX","LU0889566641.SGD","LU0345770993.USD","LU2361044949.HKD","LU2361045086.USD","LU0306806265.USD","LU2552382058.USD","LU0225771236.USD","BMY","LU0889565916.HKD","LU1934455194.USD","LU2491050071.SGD","LU0545562505.USD","LU0070217475.USD","LU0868494617.USD","IE0009355771.USD","LU1032955483.USD","LU0069063385.USD","BK4139","BK4588","LU0471298777.SGD","IE0002270589.USD","LU1267930813.SGD","LU2213496289.HKD","LU0130102774.USD","PFE","LU1043141396.HKD","LU1670710661.SGD","LU1983299246.USD","BK4550","BK4566","BK4599","LU1066053197.SGD","LU2168564065.EUR","SGXZ57979304.SGD","XLV","LU0882574055.USD","IE00BSNM7G36.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658396419","title":"Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658396419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658396419?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:47","pubTimestamp":1786366034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237438978.USD","TBXU","BBH","LU1035775433.USD","LU0417517546.SGD","LU2324357040.USD","IBB","LU2362541513.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4567","GNMX","LU0256863811.USD","LU1093756325.SGD","LU2417539215.USD","LU0058720904.USD","IBBQ","LU0889565916.HKD","IE0002270589.USD","LU1430594728.SGD","LU1778281490.HKD","LU0289739699.SGD","LU2236285917.USD","LU2362541273.HKD","LU2456880835.USD","BK4139","PBE","IE00B19Z3581.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","IE00B19Z9Z06.USD","LU1585245621.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","VRTX","LU2362540622.SGD","IE00B2B36J28.USD","IDNA","IE00BZ9MQY76.HKD","LU0432979614.USD","IE00BJT1NW94.SGD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","BK4532","LU0079474960.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935018","title":"Erasca Appoints Charles Fuchs as President of R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935018","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935018?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:07","pubTimestamp":1786363655,"startTime":"0","endTime":"0","summary":"Erasca appoints Charles Fuchs as president of R&DErasca named Charles S. Fuchs president of research and development, effective immediately.Fuchs most recently served as chief medical officer at Tubul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL46mF8m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","TMED","IBB","LU0965509010.AUD","LU1839511570.USD","LU2087621335.USD","LU1430594728.SGD","BK4583","LU2210150020.SGD","LU1023059063.AUD","BK4568","LU0320765992.SGD","LU0114720955.EUR","LU0861579265.USD","LU1061106388.HKD","LU1934455863.HKD","LU0965509283.SGD","BMED","NDAQ","LU0289739699.SGD","LU1585245621.USD","BK4578","LU0058720904.USD","IBBQ","LU1057294990.SGD","LU2468319806.SGD","BK4532","BK4585","GILD","MEDI","TBXU","LU1934455194.USD","LU0965509101.SGD","ERAS","IE0002270589.USD","LU1778281490.HKD","LU0122379950.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU1037948541.HKD","BBH","BIB","BCDF","SG9999014021.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270935","title":"Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:03","pubTimestamp":1786363413,"startTime":"0","endTime":"0","summary":"Sionna scraps genetic disorder drug program after trial setback; shares tankAug 10 (Reuters)-Sionna TherapeuticsSION.Osaid on Monday it would stop developing its experimental drug as an addition to st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","SG9999001176.SGD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU2417539215.USD","LU2362540622.SGD","BK4585","SION","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","LU1585245621.USD","BBH","LU0058720904.USD","GNMX","IDNA","IE00B19Z3581.USD","LU0256863811.USD","BK4588","LU0320765992.SGD","LU0061475181.USD","LU2456880835.USD","IE00B19Z3B42.SGD","LU0823416689.USD","PBE","BK4532","LU2236285917.USD","IE0002270589.USD","LU1674673691.USD","TBXU","LU2324357040.USD","LU2362541513.USD","LU0289739699.SGD","IE00B19Z9Z06.USD","LU0417517546.SGD","SG9999013999.USD","BK4533","IE00B2B36J28.USD","LU1035775433.USD","BK4567","IBB","IBBQ","IE00B19Z9P08.USD","LU2362541273.HKD","VRTX","LU1069344957.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1674673428.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891989","title":"Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:33","pubTimestamp":1786350780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 0.9% to 5.05 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.7% and Amgen Inc. remained unchanged.Trading volume totaled 86.6 million shares, compared to the 50-day average of 101.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1023059063.AUD","BIB","BK1515","BK4581","IE00BJJMRZ35.SGD","LU0109394709.USD","SG9999001440.SGD","PBE","BK4585","IBBQ","BK4588","BK1589","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","IE00BZ08YT58.USD","LU1983299246.USD","LU1057294990.SGD","LU2242646821.SGD","LU0889565916.HKD","BK4566","LU0289739699.SGD","IE00BZ08YS42.EUR","LU2089984988.USD","BK1521","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","BK4139","BK4534","LU1571399168.USD","LU2468319806.SGD","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","HK0000165453.HKD","IBB","IE00BZ08YR35.GBP","LU0122379950.USD","TBXU","01177","LU2242652126.USD","BK1191","LU1061106388.HKD","AMGN","PJP","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658042600","title":"Amgen Inc : HSBC Raises Target Price to $445 from $425","url":"https://stock-news.laohu8.com/highlight/detail?id=2658042600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658042600?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:30","pubTimestamp":1786343453,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44709K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0122379950.USD","BK4585","BBH","IE00B4R5TH58.HKD","LU1023059063.AUD","PBE","LU0868494617.USD","IE00BJJMRZ35.SGD","BK4581","IBBQ","LU0109394709.USD","LU1057294990.SGD","LU2468319806.SGD","LU0889565916.HKD","PJP","BK4588","BK4566","IE0002141913.USD","BK4534","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0058720904.USD","SG9999001440.SGD","TBXU","IE0009355771.USD","LU2089984988.USD","LU2112291526.USD","LU0289739699.SGD","LU1571399168.USD","IBB","LU0320765992.SGD","AMGN","BK4533","BIB","BK4599","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4139","IE00B2B36J28.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657402621","title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657402621","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657402621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:46","pubTimestamp":1786142807,"startTime":"0","endTime":"0","summary":"Amgen SVP, Chief Compliance Officer Nancy Grygiel sells 2,970 shares for $1.2 millionAmgen SVP and chief compliance officer Nancy A. Grygiel exercised stock options on Aug. 6, 2026, acquiring 2,970 co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL4RnJzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4599","LU2242652126.USD","IE0009355771.USD","BIB","IBBQ","BBH","LU2468319806.SGD","LU0122379950.USD","PBE","BK4566","LU0320765992.SGD","LU2089984988.USD","LU0868494617.USD","BK4581","LU0058720904.USD","LU1061106388.HKD","BK4534","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0289739699.SGD","LU0889565916.HKD","TBXU","IE00BFTCPJ56.SGD","BK4585","BK4588","IBB","PJP","BK4139","IE0002141913.USD","BK4533","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621940","title":"Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621940?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:05","pubTimestamp":1786140332,"startTime":"0","endTime":"0","summary":"Michael Okunewitch, an analyst from Maxim Group, reiterated the Buy rating on Gilead Sciences. The associated price target remains the same with $1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","LU0320765992.SGD","GILD","BK4568","LU1066053197.SGD","BIB","SG9999015952.SGD","SG9999015986.USD","LU0965509010.AUD","BK4139","IBB","LU0965508806.USD","MEDI","LU2087621335.USD","LU0058720904.USD","IE00B19Z3581.USD","LU0823416689.USD","LU1430594728.SGD","LU1674673428.USD","BK4550","LU0889565916.HKD","LU1023059063.AUD","LU1037948897.HKD","TMED","BMED","LU1674673691.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU1057294990.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","BK4583","LU0882574055.USD","BBH","LU1066051498.USD","LU0861579265.USD","LU1061106388.HKD","BK4588","LU1934455194.USD","BK4566","LU0965509283.SGD","LU0289739699.SGD","IE0002270589.USD","LU0114720955.EUR","LU1934455863.HKD","TBXU","LU1839511570.USD","BK4532","IBBQ","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657749626","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657749626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657749626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:36","pubTimestamp":1786134960,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.80% to $133.21 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.62% to 7,757.64 and the Dow Jones Industrial Average  rising 0.28% to 54,036.93.The stock's rise snapped a two-day losing streak.Gilead Sciences Inc. closed 15.31% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.88% to $259.24, Pfizer Inc.  rose 2.14% to $26.76, and Abbott Laboratories  fell 0.14% to $107.81.Trading volume  eclipsed its 50-day average volume of 8.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","GILD","LU1934455194.USD","LU1066051498.USD","BK4139","LU0861579265.USD","LU2087621335.USD","LU2112291526.USD","LU0965509010.AUD","LU2324357040.USD","TBXU","BK4585","IE00B7SZLL34.SGD","LU1839511570.USD","LU1674673691.USD","LU0889565916.HKD","BBH","IBBQ","SG9999015952.SGD","IE00B3T34201.USD","LU1057294990.SGD","LU1430594728.SGD","BK4583","IE00B19Z3B42.SGD","BIB","SG9999015986.USD","MEDI","IE00B19Z3581.USD","BK4568","LU1037948541.HKD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0114720955.EUR","LU0823416689.USD","LU0965509101.SGD","BMED","LU0965509283.SGD","LU1934455863.HKD","BK4566","IE0002270589.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","BK4578","LU1571399168.USD","LU1778281490.HKD","LU1934455277.USD","BK4550","LU0122379950.USD","BK4532","BK4588","LU1066053197.SGD","LU0882574055.USD","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","IBB","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","LU1061106388.HKD","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626282","title":"Moderna Inc. Stock Climbs 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626282?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:33","pubTimestamp":1786134780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 9.9% to $59.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.The stock's rise snapped a two-day losing streak.Moderna Inc. closed 30.9% short of its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $259.24, Pfizer Inc. rose 2.1% to $26.76, and Gilead Sciences Inc. rose 1.80% to $133.21.Trading volume totaled 6.8 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BIB","MRNA","SG9999015952.SGD","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","BK4550","WDNA","BK4583","GILD","LU0861579265.USD","LU2468319806.SGD","IDNA","MRNY","LU1066051498.USD","LU0965509010.AUD","BK4588","LU0320765992.SGD","LU1037948897.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","LGHT","LU1934455277.USD","LU1023059063.AUD","GNOM","LU2112291526.USD","LU0823416689.USD","LU0882574055.USD","BK4532","TMED","BK4551","IE0002270589.USD","LU0889565916.HKD","LU1037948541.HKD","LU1430594728.SGD","SG9999015978.USD","TBXU","IE00B7SZLL34.SGD","LU0114720955.EUR","IBB","IBBQ","LU1674673428.USD","IE00BZ1G4Q59.USD","BK4566","BMED","BK4501","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657469640","title":"Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657469640","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657469640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:36","pubTimestamp":1786120560,"startTime":"0","endTime":"0","summary":"Replimune Group received Food and Drug Administration clearance for its experimental skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.Th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4534","AMGN","PBE","IE0002141913.USD","FTXH","PJP","TBXU","LU0225284248.USD","BK4585","LU0306807586.USD","IHE","LU1093756325.SGD","BBH","IBBQ","LU0061475181.USD","LU1868837136.USD","LU1989771016.USD","LU0985481810.HKD","IOVA","LU1670711123.USD","LU2133065610.SGD","BIB","REPL","LU1718418525.SGD","BK4007","LU1883839398.USD","LU0114720955.EUR","LU2242646821.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU0237698245.USD","LU1983299246.USD","BK4533","LU0868494617.USD","BK4532","LU2468319806.SGD","LU2089984988.USD","LU1323610961.USD","IBB","LU1093756168.USD","LU0289739699.SGD","LU0306806265.USD","LU1023059063.AUD","LU1868836591.USD","LU0225771236.USD","LU1061106388.HKD","SG9999001440.SGD","LU0321505868.SGD","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657249641","title":"Sanofi, Regeneron Seem Keen to Keep Working Together","url":"https://stock-news.laohu8.com/highlight/detail?id=2657249641","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657249641?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:06","pubTimestamp":1786111560,"startTime":"0","endTime":"0","summary":"1406 GMT - Drugmakers Sanofi and Regeneron Pharmaceuticals seem to be exploring ways to work more strategically together again, Jefferies analysts say in a research note. They could work on extending the lifecycle of their blockbuster drug Dupixent or on next-generation immunology assets, even though neither company disclosed a new collaboration in recent earnings calls, the analysts say. The tone from executives at both Sanofi and Regeneron seemed to shift from their somewhat transactional relationship over the last few years, Jefferies says. Sanofi shares rise 2%, Regeneron's are little changed.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY","BK4585","BBH","SNYNF","LU2106854487.HKD","LU2237438978.USD","IBBQ","LU0109394709.USD","LU2362541513.USD","LU2468319806.SGD","IE00BFXG1179.USD","LU0889565916.HKD","LU1974910355.USD","LU2023250504.SGD","LU0114720955.EUR","LU0823416689.USD","BK4588","LU0823434740.USD","LU2362541273.HKD","LU0058720904.USD","TBXU","LU2089984988.USD","LU0289739699.SGD","IBB","LU0320765992.SGD","LU0882574055.USD","BK4007","LU0823434583.USD","LU0053666078.USD","LU1917777945.USD","REGN","LU2362540622.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615971","title":"Sino Biopharmaceutical Stock Climbs 3.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615971","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615971?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:30","pubTimestamp":1786091400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 3.3% to 5.10 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 25668.03.This was the stock's second consecutive day of gains.Sino Biopharmaceutical Ltd. closed 44% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 2.2% and Amgen Inc. remained unchanged.Trading volume totaled 88.6 million shares, compared to the 50-day average of 101.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","BK1191","IE00BZ08YT58.USD","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","IE00BZ08YR35.GBP","BK4585","TBXU","01177","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","IE00BZ08YS42.EUR","LU1061106388.HKD","BK4588","HK0000165453.HKD","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK1521","BK4533","BK1515","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657369495","title":"Oxford Biomedica trims 2026 outlook but leans on record client wins and growing pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657369495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657369495?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:11","pubTimestamp":1786083103,"startTime":"0","endTime":"0","summary":"An update from Oxford BioMedica ( ($GB:OXB) ) is now available. Oxford Biomedica, a specialist cell and gene therapy CDMO, reported around 9% reven...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oxford-biomedica-trims-2026-outlook-but-leans-on-record-client-wins-and-growing-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","GNOM","OXM","IDNA","IBB","WDNA","TBXU","HELX","BK4588","CNCR","LFSC","SYNB","IBBQ","BK4202","JDOC","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682986","title":"Moderna Inc. Stock Sheds 4.3%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682986","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682986?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:35","pubTimestamp":1786048500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.3% to $53.86 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,348.35 and Dow Jones Industrial Average falling 0.9% to 53,885.10.This was the stock's second consecutive day of losses.Moderna Inc. closed 37.1% short of its 52-week high of $85.60, which the company reached on July 6th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.2% to $256.98, Pfizer Inc. rose 1.5% to $26.20, and Gilead Sciences Inc. fell 0.68% to $130.86.Trading volume totaled 5.5 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4548","BK4501","LU0965509010.AUD","IBBQ","LGHT","BK4532","IE00B19Z3581.USD","SG9999015945.SGD","BBH","LU1674673691.USD","IE00BZ1G4Q59.USD","MRNA","LU1066053197.SGD","IE00B19Z3B42.SGD","TBXU","LU1037948897.HKD","LU1430594728.SGD","LU1934455194.USD","LU1571399168.USD","IDNA","BK4551","BK4583","LU1934455863.HKD","TMED","BK4139","LU0823416689.USD","BK4533","LU2087621335.USD","BK4578","LU0965508806.USD","LU1061106388.HKD","MRNX","LU2112291526.USD","GNOM","LU0058720904.USD","BMED","WDNA","IBB","BK4568","IE00B3T34201.USD","IE00B7SZLL34.SGD","BK4585","GILD","LU1037948541.HKD","SG9999015978.USD","MRNY","LU0289739699.SGD","BIB","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657665459","title":"Regeneron Posts Transcript of Q2 2026 Earnings Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665459","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665459?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:48","pubTimestamp":1786042119,"startTime":"0","endTime":"0","summary":"Regeneron posts transcript of Q2 2026 earnings conference callRegeneron’s Q2 2026 earnings call drew CEO Leonard Schleifer, CSO George Yancopoulos, Commercial EVP Marion McCourt, CFO Christopher Fenimore.Revenue rose 17% to USD 4.3 billion; non-GAAP EPS increased 11% to USD 14.29, including a USD 0.99 hit from acquired IPR&D charges.EYLEA HD U.S. net sales reached USD 596 million, up 52%; management targeted EYLEA HD prefilled-syringe clearance before year-end using more than two CMOs.Sanofi collaboration revenue hit USD 2.2 billion; Fenimore flagged a step-up starting Q3 as the USD 3.1 billion Sanofi development balance was fully repaid.Management guided to August FDA action for garetosmab in FOP; November FDA decision for cemdisiran in gMG; PNH registrational readout in Q4.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL67NH1y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2023250504.SGD","LU0289739699.SGD","BK4585","LU0889565916.HKD","LU2362540622.SGD","LU2362541273.HKD","LU0320765992.SGD","LU2106854487.HKD","BK4139","BK4588","LU0823434740.USD","LU0058720904.USD","LU0114720955.EUR","LU2362541513.USD","LU1974910355.USD","REGN","LU0053666078.USD","LU0109394709.USD","LU0823416689.USD","LU2468319806.SGD","LU2237438978.USD","BBH","LU0823434583.USD","LU2089984988.USD","LU0882574055.USD","LU1917777945.USD","IBB","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567836","title":"Vortex Energy Study Confirms Major Salt Structure and New Target at Robinsons River","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:59","pubTimestamp":1786035577,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) just unveiled an announcement. Vortex Energy Corp. reported final results from a technical study by Lonquist Fi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-study-confirms-major-salt-structure-and-new-target-at-robinsons-river?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","LU2456880835.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2089984988.USD","SG9999013999.USD","LU1778281490.HKD","BIB","LU0417517546.SGD","LU2362541273.HKD","IE0002141913.USD","LU0061475181.USD","BK4588","LU1093756168.USD","LU1035775433.USD","IDNA","VRTX","BK4567","LU2462157665.USD","IBBQ","BBH","LU0256863811.USD","LU1430594728.SGD","SG9999001176.USD","LU2362540622.SGD","IE00B894F039.SGD","BK4532","TBXU","LU2468319806.SGD","LU0109394709.USD","IE00BZ9MQY76.HKD","LU2237438978.USD","LU2417539215.USD","IE00B4R5TH58.HKD","LU1674673428.USD","BK4585","PBE","SGXZ57979304.SGD","SG9999001176.SGD","LU0889565916.HKD","LU2236285917.USD","IBB","GNMX","LU1069344957.HKD","LU2324357040.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657739653","title":"Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657739653","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657739653?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:43","pubTimestamp":1786031036,"startTime":"0","endTime":"0","summary":"Aug 6 (Reuters) - Regeneron Canada::*REGENERON CANADA: LIBTAYO RECEIVES HEALTH CANADA APPROVAL FOR ADJUVANT TREATMENT OF HIGH-RISK CUTANEOUS SQUAMOUS CELL CARCINOMA((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 06-AUG-202615:30:00.257 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nRSD2CjPQd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4139","LU2237438978.USD","LU0114720955.EUR","IBB","LU0053666078.USD","LU0109394709.USD","LU0823434740.USD","LU1974910355.USD","LU0889565916.HKD","LU2023250504.SGD","LU0823416689.USD","LU1917777945.USD","LU0882574055.USD","LU0320765992.SGD","LU0289739699.SGD","LU2362540622.SGD","LU2468319806.SGD","BK4585","IBBQ","LU2106854487.HKD","BBH","LU0823434583.USD","LU2089984988.USD","TBXU","LU2362541273.HKD","REGN","LU2362541513.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657653754","title":"Regeneron announces Health Canada approval of new indication for Libtayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657653754","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657653754?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:35","pubTimestamp":1786030528,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Canada announced that Health Canada has issued a Notice of Compliance for Libtayo for the adjuvant treatment of adult patients wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-health-canada-approval-of-new-indication-for-libtayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-health-canada-approval-of-new-indication-for-libtayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU2362541513.USD","REGN","BK4139","TBXU","BK4585","LU0889565916.HKD","BBH","IBBQ","LU1974910355.USD","LU2023250504.SGD","LU0823416689.USD","LU0114720955.EUR","LU2237438978.USD","LU2362541273.HKD","LU2362540622.SGD","LU0823434740.USD","LU0823434583.USD","BK4588","LU1917777945.USD","LU0882574055.USD","LU2468319806.SGD","LU2089984988.USD","IBB","LU0053666078.USD","LU0109394709.USD","LU0289739699.SGD","LU2106854487.HKD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657653183","title":"Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2657653183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657653183?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:30","pubTimestamp":1786030236,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN4431G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","LU0823434583.USD","IBBQ","LU0058720904.USD","LU0823416689.USD","BK4588","LU1974910355.USD","LU0109394709.USD","BBH","IBB","LU0882574055.USD","LU2362541273.HKD","LU0053666078.USD","LU2106854487.HKD","LU2362541513.USD","REGN","BK4585","LU0823434740.USD","LU2468319806.SGD","LU0289739699.SGD","LU2023250504.SGD","BK4139","LU2362540622.SGD","LU0889565916.HKD","LU2237438978.USD","LU1917777945.USD","LU0114720955.EUR","LU0320765992.SGD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}